NCT03583567View on ClinicalTrials.gov

Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Protamine Adverse Reaction
Interventions
DRUG

Chlorpheniramine and ranitidine

Patient will receive intravenous chlorpheniramine and ranitidine prior to protamine.

DRUG

0.9% Normal Saline

Patient will receive normal saline as placebo.

Trial Locations (1)

10700

Siriraj Hospital, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT03583567 - Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine | Biotech Hunter | Biotech Hunter